학술논문

CRISPR/Cas9 Gene Editing of Immune Checkpoint Receptor NKG2A Improves the Efficacy of Primary CD33-CAR-NK Cells Against AML
Document Type
Abstract
Source
In Blood 15 November 2022 140 Supplement 1:4558-4559
Subject
Language
ISSN
0006-4971